Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer | Published in Journal of Health Economics and Outcomes Research

Loading [Contrib]/a11y/accessibility-menu.js

Metrics
Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer

Franklin D. Gaylis, Bruno Emond, Ameur M. Manceur, Anabelle Tardif-Samson, Laura Morrison, Dominic Pilon, Patrick Lefebvre, Lorie A. Ellis, Hiremagalur Balaji, Andrea Ireland,

Bacillus Calmette-Guérinnon-muscle invasive bladder cancercarcinoma in situtreatment guidelines

• https://doi.org/10.36469/001c.124208

Pageviews and PDF downloads

Pageviews Downloads

14 past 7 days

Last 7 days Last 30 days Last 90 days All time

Top Countries
US	12
CA	2